Abcely

Nantes, France

Abcely is a biotech firm that is working on a novel anti-cancer medication.

$2.6M raised

Sep 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Abcely raised?

Abcely has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are Abcely's investors?

Abcely's investors include GO CAPITAL, Angels Santé, Institut de Cancérologie de l'Ouest (ICO).

Where is Abcely headquartered?

Abcely is headquartered in Nantes, France.

What does Abcely do?

Abcely is a biotech firm that is working on a novel anti-cancer medication.

What stage is Abcely at?

Abcely is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2023.

MLA

"Abcely — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/abcely. Accessed July 2, 2026.

APA

VCBacked. (2023). Abcely — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/abcely

Wikipedia (cite web)

{{cite web |title=Abcely — Funding & Investors |url=https://www.vcbacked.co/company/abcely |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2023.